DNA methyltransferase 3B gene promoter and interleukin-1 receptor antagonist polymorphisms in childhood immune thrombocytopenia

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Pesmatzoglou, Margarita ^a   Lourou, Marilena ^a   Goulielmos, George N ^a   Stiakaki, Eftichia ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; DNA (CYTOSINE 5) METHYLTRANSFERASE; INTERLEUKIN 1 RECEPTOR;

ARTICLE; CHILD; CHILDHOOD IMMUNE THROMBOCYTOPENIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNMT3B GENE; EPIGENETICS; FEMALE; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IL 1 RA GENE; INTRON; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOPENIA; VARIABLE NUMBER OF TANDEM REPEAT; ADOLESCENT; ALLELE; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFANT; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; ALLELES; CHILD; CHILD, PRESCHOOL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTRONS; MALE; MINISATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, INTERLEUKIN-1; THROMBOCYTOPENIA;

EID: 84867350040     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/352059     Document Type: Article

References (47)

1. Cines D. B., Blanchette V. S., Medical progress: immune thrombocytopenic purpura. New England Journal of Medicine 2002 346 13 995 1008 2-s2.0-0037187949 10.1056/NEJMra010501 (Pubitemid 34983251)
2. Stiakaki E., Perdikogianni C., Thomou C., Markaki E.-A., Katzilakis N., Tsirigotaki M., Kalmanti M., Idiopathic thrombocytopenic purpura in childhood: twenty years of experience in a single center. Pediatrics International 2012 54 4 524 527 2-s2.0-84864396931 10.1111/j.1442-200X.2012.03606.x
3. Berchtold P., Müller D., Beardsley D., Fujisawa K., Kaplan C., Kekomäki R., Lipp E., Morell-Kopp M. C., Kiefel V., McMillan R., Von Dem Borne A. E. G. K., Imbach P., International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies. British Journal of Haematology 1997 96 3 477 483 2-s2.0-8044241571 10.1046/j.1365-2141.1997. d01-2064.x (Pubitemid 27087230)
4. George J. N., Woolf S. H., Raskob G. E., Wasser J. S., Aledort L. M., Ballem P. J., Blanchette V. S., Bussel J. B., Cines D. B., Kelton J. G., Lichtin A. E., McMillan R., Okerbloom J. A., Regan D. H., Warrier I., Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996 88 1 3 40 2-s2.0-8944225498 (Pubitemid 26230668)
5. Zhou B., Zhao H., Yang R. C., Han Z. C., Multi-dysfunctional pathophysiology in ITP. Critical Reviews in Oncology/Hematology 2005 54 2 107 116 2-s2.0-17444383068 10.1016/j.critrevonc.2004.12.004 (Pubitemid 40544948)
6. Stasi R., Evangelista M. L., Stipa E., Buccisano F., Venditti A., Amadori S., Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thrombosis and Haemostasis 2008 99 1 4 13 2-s2.0-38349190476 10.1160/TH07-08-0513
7. Andersson J., Cytokines in idiopathic thrombocytopenic purpura (ITP). Acta Paediatrica 1998 87 424 61 64 2-s2.0-0031680266 (Pubitemid 28410864)
8. Semple J. W., Milev Y., Cosgrave D., Mody M., Hornstein A., Blanchette V., Freedman J., Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood 1996 87 10 4245 4254 2-s2.0-0029964421 (Pubitemid 26152268)
9. Pehlivan M., Okan V., Sever T., Balci Oguzkan S., Yilmaz M., Babacan T., Pehlivan S., Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets 2011 22 8 588 595 2-s2.0-84855203741 10.3109/09537104.2011.577255
10. Carcao M. D., Blanchette V. S., Wakefield C. D., Stephens D., Ellis J., Matheson K., Denomme G. A., Fc γ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. British Journal of Haematology 2003 120 1 135 141 2-s2.0-0037207507 10.1046/j.1365-2141.2003.04033.x (Pubitemid 36056921)
11. Foster C. B., Zhu S., Erichsen H. C., Lehrnbecher T., Hart E. S., Choi E., Stein S., Smith M. W., Steinberg S. M., Imbach P., Kühne T., Chanock S. J., Polymorphisms in inflammatory cytokines and fc γ receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. British Journal of Haematology 2001 113 3 596 599 2-s2.0-0034993759 10.1046/j.1365-2141. 2001.02807.x (Pubitemid 32524376)
12. Satoh T., Pandey J. P., Okazaki Y., Yasuoka H., Kawakami Y., Ikeda Y., Kuwana M., Single nucleotide polymorphisms of the inflammatory cytokine genes in adults with chronic immune thrombocytopenic purpura. British Journal of Haematology 2004 124 6 796 801 2-s2.0-1642386746 10.1111/j.1365-2141.2004.04843. x (Pubitemid 38365785)
13. Wu K. H., Peng C. T., Li T. C., Wan L., Tsai C. H., Lan S. J., Chang M. C., Tsai F. J., Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura. British Journal of Haematology 2005 128 6 849 852 2-s2.0-15944389435 10.1111/j.1365-2141.2005.05385.x (Pubitemid 40444880)
14. Wu K. H., Peng C. T., Li T. C., Wan L., Tsai C. H., Tsai F. J., Interleukin-1 β exon 5 and interleukin-1 receptor antagonist in children with immune thrombocytopenic purpura. Journal of Pediatric Hematology/Oncology 2007 29 5 305 308 2-s2.0-34248142308 10.1097/MPH.0b013e3180590615 (Pubitemid 46707510)
15. Hewagama A., Richardson B., The genetics and epigenetics of autoimmune diseases. Journal of Autoimmunity 2009 33 1 3 11 2-s2.0-67349236051 10.1016/j.jaut.2009.03.007
16. Richardson B., Primer: epigenetics of autoimmunity. Nature Clinical Practice Rheumatology 2007 3 9 521 527 2-s2.0-34548398164 10.1038/ncprheum0573 (Pubitemid 47351397)
17. Richardson B., DNA methylation and autoimmune disease. Clinical Immunology 2003 109 1 72 79 2-s2.0-0142247168 10.1016/S1521-6616(03)00206-7 (Pubitemid 37324744)
18. Liu K., Wang Y. F., Cantemir C., Muller M. T., Endogenous assays of DNA methyltransferases: evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo. Molecular and Cellular Biology 2003 23 8 2709 2719 2-s2.0-0037383398 10.1128/MCB.23.8.2709-2719.2003 (Pubitemid 36403072)
19. Okano M., Bell D. W., Haber D. A., Li E., DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999 99 3 247 257 2-s2.0-0033615717 10.1016/S0092-8674(00)81656-6 (Pubitemid 29519904)
20. Chédin F., Lieber M. R., Hsieh C. L., The DNA methyltransferase- like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proceedings of the National Academy of Sciences of the United States of America 2002 99 26 16916 16921 2-s2.0-0037168587 10.1073/pnas.262443999 (Pubitemid 36034073)
21. Taberlay P. C., Jones P. A., DNA methylation and cancer. Progress in Drug Research 2011 67 1 23 2-s2.0-79952111851
22. Clark S. J., Melki J., DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 2002 21 35 5380 5387 2-s2.0-0037068393 10.1038/sj.onc.1205598 (Pubitemid 34983474)
23. Shen H., Wang L., Spitz M. R., Hong W. K., Mao L., Wei Q., A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Research 2002 62 17 4992 4995 2-s2.0-0036735345 (Pubitemid 34984424)
24. Wang L., Rodriguez M., Kim E. S., Xu Y., Bekele N., El-Naggar A. K., Hong W. K., Mao L., Oh Y. W., A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. International Journal of Oncology 2004 25 4 993 999 2-s2.0-16644362218
25. Bao Q., He B., Pan Y., Tang Z., Zhang Y., Qu L., Xu Y., Zhu C., Tian F., Wang S., Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer. International Journal of Colorectal Disease 2011 26 9 1107 1112 2-s2.0-79955003727 10.1007/s00384-011-1199-3
26. Lee S. J., Jeon H. S., Jang J. S., Park S. H., Lee G. Y., Lee B. H., Kim C. H., Kang Y. M., Lee W. K., Kam S., Park R. W., Kim I. S., Cho Y. L., Jung T. H., Park J. Y., DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 2005 26 2 403 409 2-s2.0-13844267367 10.1093/carcin/bgh307 (Pubitemid 40246562)
27. Park B. L., Kim L. H., Shin H. D., Park Y. W., Uhm W. S., Bae S. C., Association analyses of DNA methyltransferase-1 (DNMT1) polymorphisms with systemic lupus erythematosus. Journal of Human Genetics 2004 49 11 642 646 2-s2.0-15244341292 10.1007/s10038-004-0192-x (Pubitemid 40385254)
28. Nam E. J., Kim K. H., Han S. W., Cho C. M., Lee J., Park J. Y., Kang Y. M., The -283C/T polymorphism of the DNMT3B gene influences the progression of joint destruction in rheumatoid arthritis. Rheumatology International 2010 30 10 1299 1303 2-s2.0-77955549359 10.1007/s00296-009-1141-y
29. Montgomery K. G., Liu M. C., Eccles D. M., Campbell I. G., The DNMT3B C>T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Research 2004 6 4 390 394 2-s2.0-7044254997
30. Robertson K. D., Keyomarsi K., Gonzales F. A., Velicescu M., Jones P. A., Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G0/G1 to S phase transition in normal and tumor cells. Nucleic Acids Research 2000 28 10 2108 2113 2-s2.0-0034658196 (Pubitemid 30255532)
31. Meda F., Folci M., Baccarelli A., Selmi C., The epigenetics of autoimmunity. Cellular and Molecular Immunology 2011 8 3 226 236 2-s2.0-79955675794 10.1038/cmi.2010.78
32. Javierre B. M., Richardson B., A new epigenetic challenge: systemic lupus erythematosus. Advances in Experimental Medicine and Biology 2011 711 117 136 2-s2.0-79958260145
33. Zhu X., Liang J., Li F., Yang Y., Xiang L., Xu J., Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus. International Journal of Dermatology 2011 50 6 697 704 2-s2.0-79956191491 10.1111/j.1365-4632.2010.04804.x
34. Chen Z., Zhou Z., Chen X., Xu J., Liu A., Du W., Gu D., Ge J., Guo Z., Wang X., Dong X., Ren Q., Yang R., Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese population. Journal of Clinical Immunology 2008 28 5 399 404 2-s2.0-51349090553 10.1007/s10875-008-9198-z
35. Tao J., Yang M., Chen Z., Huang Y., Zhao Q., Xu J., Ren H., Zhao H., Chen Z., Ren Q., Yang R., Decreased DNA methyltransferase 3A and 3B mRNA expression in peripheral blood mononuclear cells and increased plasma SAH concentration in adult patients with idiopathic thrombocytopenic purpura. Journal of Clinical Immunology 2008 28 5 432 439 2-s2.0-51349088958 10.1007/s10875-008-9223-2
36. Emonts M., Hazes M. J. M. W., Houwing-Duistermaat J. J., van der Gaast-de Jongh C. E., de Vogel L., Han H. K. H., Wouters J. M. G. W., Laman J. D., Dolhain R. J. E. M., Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Medical Genetics 2011 12, article 36 2-s2.0-79952322216 10.1186/1471-2350-12-36
37. Kariuki S. N., Niewold T. B., Genetic regulation of serum cytokines in systemic lupus erythematosus. Translational Research 2010 155 3 109 117 2-s2.0-76549136591 10.1016/j.trsl.2009.08.012
38. You C. G., Li J. F., Xie X. D., Zhu Y., Li P. Q., Chen Y. R., Association of interleukin-1 genetic polymorphisms with the risk of rheumatoid arthritis in Chinese population. Clinical Chemistry and Laboratory Medicine 2007 45 8 968 971 2-s2.0-34548717681 10.1515/CCLM.2007.156 (Pubitemid 47424847)
39. Lee Y. H., Kim H. J., Rho Y. H., Choi S. J., Ji J. D., Song G. G., Interleukin-1 receptor antagonist gene polymorphism and rheumatoid arthritis. Rheumatology International 2004 24 3 133 136 2-s2.0-2942748644 10.1007/s00296-003-0337-9 (Pubitemid 38797624)
40. Carreira P. E., Gonzalez-Crespo M. R., Ciruelo E., Pablos J. L., Santiago B., Gomez-Camara A., Gomez-Reino J. J., Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population. Arthritis and Rheumatism 2005 52 10 3015 3019 2-s2.0-26844563660 10.1002/art.21287 (Pubitemid 41447080)
41. Blakemore A. I. F., Tarlow J. K., Cork M. J., Gordon C., Emery P., Duff G. W., Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis and Rheumatism 1994 37 9 1380 1385 2-s2.0-0027948470 10.1002/art.1780370917 (Pubitemid 24320758)
42. Huang C. M., Wu M. C., Wu J. Y., Tsai F. J., Interleukin-1 receptor antagonist gene polymorphism in Chinese patients with systemic lupus erythematosus. Clinical Rheumatology 2002 21 3 255 257 2-s2.0-0036066322 10.1007/s10067-002-8292-5 (Pubitemid 34785016)
43. McGarry F., Neilly J., Anderson N., Sturrock R., Field M., A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology 2001 40 12 1359 1364 2-s2.0-0035684706
44. Mansfield J. C., Holden H., Tarlow J. K., Di Giovine F. S., McDowell T. L., Wilson A. G., Holdsworth C. D., Duff G. W., Novel genetic association between ulcerative colitis and the anti- inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994 106 3 637 642 2-s2.0-0028123647
45. Blakemore A. I. F., Cox A., Gonzalez A. M., Maskill J. K., Hughes M. E., Wilson R. M., Ward J. D., Duff G. W., Interleukin-1 receptor antagonist allele (IL1RN2) associated with nephropathy in diabetes mellitus. Human Genetics 1996 97 3 369 374 2-s2.0-0030062817
46. Santtila S., Savinainen K., Hurme M., Presence of the IL-1RA allele 2 (IL1RN2) is associated with enhanced IL-1 β production in vitro. Scandinavian Journal of Immunology 1998 47 3 195 198 2-s2.0-0031955425 10.1046/j.1365-3083.1998.00300.x (Pubitemid 28153395)
47. Hurme M., Santtila S., IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1 β genes. European Journal of Immunology 1998 28 8 2598 2602 2-s2.0-0031927564 10.1002/(SICI)1521- 4141(199808)28:082598::AID-IMMU2598>3.0.CO;2-K (Pubitemid 28362734)